Literature DB >> 8282184

Genomic fingerprinting of Clostridium difficile isolates by using a random amplified polymorphic DNA (RAPD) assay.

F Barbut1, N Mario, M Delmée, J Gozian, J C Petit.   

Abstract

This study describes the use of a new and easy method called random amplified polymorphic DNA (RAPD) assay to distinguish strains of C. difficile. We used two single short primers (AP4 and AP5) with arbitrary nucleotide sequences in a polymerase chain reaction to amplify genomic DNA. The profiles observed after electrophoretic separation were able to distinguish 20 reference C. difficile strains previously serotyped by Delmée's method. The fingerprints of 11 epidemiologically unrelated C. difficile strains clearly yielded a DNA polymorphism between all the strains. Latterly, RAPD profiles of 11 C. difficile strains isolated from 2 independent suspected outbreaks showed, in each case, a predominant banding pattern corresponding to an epidemic strain. These results suggest that RAPD assay could be a valuable tool for epidemiological studies.

Entities:  

Mesh:

Year:  1993        PMID: 8282184     DOI: 10.1111/j.1574-6968.1993.tb06567.x

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  16 in total

1.  Phenotypic and genotypic diversity of the flagellin gene (fliC) among Clostridium difficile isolates from different serogroups.

Authors:  A Tasteyre; T Karjalainen; V Avesani; M Delmée; A Collignon; P Bourlioux; M C Barc
Journal:  J Clin Microbiol       Date:  2000-09       Impact factor: 5.948

2.  Use of pulsed-field gel electrophoresis for investigation of an outbreak of Clostridium difficile infection among geriatric patients.

Authors:  D Talon; P Bailly; M Delmée; M Thouverez; B Mulin; M Iehl-Robert; V Cailleaux; Y Michel-Briand
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-11       Impact factor: 3.267

3.  Comparison of PCR-ribotyping, arbitrarily primed PCR, and pulsed-field gel electrophoresis for typing Clostridium difficile.

Authors:  P Bidet; V Lalande; B Salauze; B Burghoffer; V Avesani; M Delmée; A Rossier; F Barbut; J C Petit
Journal:  J Clin Microbiol       Date:  2000-07       Impact factor: 5.948

4.  Genomic diversity of Clostridium perfringens strains isolated from food and human sources.

Authors:  A Afshari; A Jamshidi; J Razmyar; M Rad
Journal:  Iran J Vet Res       Date:  2016       Impact factor: 1.376

5.  Differentiation of Neisseria gonorrhoeae strains by polymerase chain reaction and restriction fragment length polymorphism of outer membrane protein IB genes.

Authors:  Q C Lau; V T Chow; C L Poh
Journal:  Genitourin Med       Date:  1995-12

6.  Prevalence and diversity of toxigenic Clostridium perfringens and Clostridium difficile among swine herds in the midwest.

Authors:  Ashley A Baker; Ellen Davis; Thomas Rehberger; Daniel Rosener
Journal:  Appl Environ Microbiol       Date:  2010-03-05       Impact factor: 4.792

7.  Genomic fingerprinting of epidemic and endemic strains of Stenotrophomonas maltophilia (formerly Xanthomonas maltophilia) by arbitrarily primed PCR.

Authors:  C J VanCouwenberghe; S H Cohen; Y J Tang; P H Gumerlock; J Silva
Journal:  J Clin Microbiol       Date:  1995-05       Impact factor: 5.948

8.  PCR ribotyping and arbitrarily primed PCR for typing strains of Clostridium difficile from a Polish maternity hospital.

Authors:  G Martirosian; S Kuipers; H Verbrugh; A van Belkum; F Meisel-Mikolajczyk
Journal:  J Clin Microbiol       Date:  1995-08       Impact factor: 5.948

9.  Evaluation of pulsed-field gel electrophoresis and rep-PCR for the epidemiological analysis of Ochrobactrum anthropi strains.

Authors:  P van Dijck; M Delmée; H Ezzedine; A Deplano; M J Struelens
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-12       Impact factor: 3.267

10.  Multilocus sequence typing analysis of human and animal Clostridium difficile isolates of various toxigenic types.

Authors:  Ludovic Lemee; Anne Dhalluin; Martine Pestel-Caron; Jean-François Lemeland; Jean-Louis Pons
Journal:  J Clin Microbiol       Date:  2004-06       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.